2019
DOI: 10.1186/s42047-018-0029-0
|View full text |Cite
|
Sign up to set email alerts
|

Epidermal growth factor receptor (EGFR) overexpression in triple-negative breast cancer: association with clinicopathologic features and prognostic parameters

Abstract: Introduction Triple-negative breast cancers are a poor prognostic group of breast cancers that don’t respond to conventional hormonal and her2neu targeted therapy. A subset of triple-negative breast cancer is known to overexpress epidermal growth factor receptor (EGFR); however prognostic significance of this biomarker has not been widely studied in our population. Therefore, we aimed to evaluate the frequency of EGFR overexpression in triple-negative breast cancer in our setup and its associat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
21
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
10

Relationship

3
7

Authors

Journals

citations
Cited by 37 publications
(29 citation statements)
references
References 28 publications
2
21
0
1
Order By: Relevance
“…Quantification of all Caspase-3 expression in the images above are assessed by calculating the sum and average of Histo Score (H-Score) 17 for group. The results can be seen as in Table 1.…”
Section: Resultsmentioning
confidence: 99%
“…Quantification of all Caspase-3 expression in the images above are assessed by calculating the sum and average of Histo Score (H-Score) 17 for group. The results can be seen as in Table 1.…”
Section: Resultsmentioning
confidence: 99%
“…Moreover, MBC is mostly negative for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu), and therefore, the treatment options are limited. In Pakistan, young-age breast cancers are common and the proportion of triple-negative breast cancer is alarmingly high [2,3]. MBC is the most common breast cancer with a triple-negative profile [4].…”
Section: Introductionmentioning
confidence: 99%
“…Owing to the lack of screening programs, patients with breast tumors typically present late, leading to a bad prognosis [ 7 ]. Moreover, young age breast tumors, including triple-negative breast tumors, are also common in this region [ 8 , 9 ]. Data regarding clinicopathologic features of rare breast tumors like EPC are especially scarce.…”
Section: Introductionmentioning
confidence: 99%